Granules India Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: GRANULES BSE: 532482

₹846.55

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #27 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Granules India Limited (this stock)	20,977	51.3	11.7%	56.0%	—	73	40	32

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹21,501 Cr

EV / EBITDA

28.2x

EV / Sales

6.20x

Market cap / Sales

6.05x

Earnings yield

1.95%

Quarterly Financials

Download CSV

Standalone Consolidated

↓ Negative

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 816 Cr, down 0.9% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 72 Cr, up 3.3% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	802	97	72	₹2.9000
March 31, 2026	877	132	99	₹4.0400
Dec. 31, 2025	895	150	112	₹4.6000
Sept. 30, 2025	892	162	121	₹4.9700
June 30, 2025	810	91	69	₹2.8600
March 31, 2025	768	127	94	₹3.8800
Dec. 31, 2024	842	119	90	₹3.7200
Sept. 30, 2024	568	56	41	₹1.7100
June 30, 2024	852	126	94	₹3.8700
March 31, 2024	940	137	97	₹4.0100
Dec. 31, 2023	984	192	143	₹5.8900
Sept. 30, 2023	1,009	156	116	₹4.8000
June 30, 2023	821	107	80	₹3.3000

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	816	894	907	899	823	799	848	571	854	944	985	1,011	821
Operating revenue	802	877	895	892	810	768	842	568	852	940	984	1,009	821
Other income	14	17	12	8	13	30	6	3	2	3	1	1	0
Operating expenses	670	702	701	680	667	651	674	465	675	751	738	801	664
Operating profit	131	175	194	211	144	117	168	103	177	189	247	208	157
Operating profit margin	16.4%	19.9%	21.7%	23.7%	17.7%	15.2%	19.9%	18.1%	20.8%	20.1%	25.1%	20.6%	19.1%
Depreciation	39	44	41	41	40	38	38	35	36	36	36	36	35
Interest	10	16	15	17	14	13	17	15	18	20	20	18	15
Exceptional items, gain / (loss)	—	—	—	—	-12	31	—	—	—	—	—	—	—
Profit before tax	97	132	150	162	91	127	119	56	126	137	192	156	107
Tax	25	33	39	41	22	33	28	15	32	39	49	40	27
Net profit	72	99	112	121	69	94	90	41	94	97	143	116	80
EPS	2.90	4.04	4.60	4.97	2.86	3.88	3.72	1.71	3.87	4.01	5.89	4.80	3.30
Net profit (TTM)	403	401	396	374	295	319	322	375	450	436	464	461	454
EPS (TTM)	16.51	16.47	16.31	15.43	12.17	13.18	13.31	15.48	18.57	18.00	19.17	19.03	18.62

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	3,474	536	401
March 31, 2025	3,030	427	319
March 31, 2024	3,755	591	436
March 31, 2023	3,931	664	499

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	-3.7%	2.3%	3,524^†	3,071^†	3,761^†	3,941^†	3,259^†	3,150^†	2,336^†	2,127^†	1,686^†	1,384^†
Operating revenue	-4.0%	2.1%	3,474	3,030	3,755	3,931	3,238^†	3,135^†	2,310^†	2,098^†	1,655^†	1,368^†
Other income	—	—	50^†	41^†	6^†	10^†	21^†	15^†	26^†	28^†	31^†	16^†
Operating expenses	—	—	2,750^†	2,465^†	2,954^†	3,093^†	2,597^†	2,275^†	—	—	—	—
Operating profit	-4.8%	-3.4%	724^†	565^†	801^†	838^†	641^†	860^†	—	—	—	—
Operating profit margin	—	—	20.8%^†	18.6%^†	21.3%^†	21.3%^†	19.8%^†	27.4%^†	—	—	—	—
Depreciation	—	—	164^†	146^†	144^†	146^†	126^†	118^†	—	—	—	—
Interest	—	—	61^†	63^†	72^†	39^†	16^†	24^†	27^†	28^†	33^†	32^†
Exceptional items, gain / (loss)	—	—	-12^†	31^†	0^†	0^†	0^†	0^†	161^†	0^†	0^†	0^†
Profit before tax	-6.9%	-6.1%	536	427	591	664	520^†	733^†	553^†	242^†	208^†	207^†
Tax	—	—	135^†	108^†	155^†	165^†	133^†	180^†	109^†	80^†	69^†	—
Net profit	-7.0%	-6.2%	401	319	436	499	387^†	553^†	444^†	162^†	139^†	143^†
EPS	-6.8%	-5.8%	16.47^†	13.18^†	18.00^†	20.35^†	15.59^†	22.19^†	17.47^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	20.8%^†	18.6%^†	21.3%^†	21.3%^†	19.8%^†	27.4%^†	—	—	—	—
EBIT margin	17.2%^†	16.2%^†	17.7%^†	17.9%^†	16.6%^†	24.1%^†	25.1%^†	12.9%^†	14.6%^†	17.5%^†
PBT margin	15.4%	14.1%	15.7%	16.9%	16.0%^†	23.4%^†	23.9%^†	11.5%^†	12.6%^†	15.1%^†
Net margin	11.5%	10.5%	11.6%	12.7%	11.9%^†	17.6%^†	19.2%^†	7.7%^†	8.4%^†	10.4%^†
Interest coverage	9.72x^†	7.81x^†	9.21x^†	18.17x^†	32.78x^†	31.83x^†	21.59x^†	9.52x^†	7.33x^†	7.43x^†
Dividend payout	—	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—	—
Current ratio	1.58x	1.43x	—	—	—	—	—	—	—	—
Quick ratio	1.15x	1.02x	—	—	—	—	—	—	—	—
Debt to equity	0.17x	0.24x	—	—	—	—	—	—	—	—
Return on equity	9.1%	9.4%	—	—	—	—	—	—	—	—
Return on assets	6.7%	6.2%	—	—	—	—	—	—	—	—
Return on capital employed	13.2%^†	13.8%^†	—	—	—	—	—	—	—	—
Asset turnover	0.58x	0.59x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	643	-1,033	444	252	391
March 31, 2025	823	-552	-340	211	612
March 31, 2024	317	-303	26	120	196
March 31, 2023	664	-96	-519	212	452
March 31, 2022	280	-318	151	325	-44

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	5,981	4,399	4,374	734	0	2,296	1,453	210	1,426	626
March 31, 2025	5,152	3,403	3,379	808	0	2,287	1,600	152	1,360	648
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.